首页> 外文OA文献 >Preparation of acetazolamide composite microparticles by supercritical antisolvent techniques
【2h】

Preparation of acetazolamide composite microparticles by supercritical antisolvent techniques

机译:超临界反溶剂技术制备乙酰唑胺复合微粒

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The possibility of preparation of ophthalmic drug delivery systems using compressed anti-solvent technology was evaluated. and RL 100 were used as drug carriers, acetazolamide was the model drug processed. Compressed anti-solvent experiments were carried out asa semi-continuous or a batch operation from a liquid solution of polymer(s) + solute dissolved in acetone. Both techniques allowed the recoveryof composite particles, but the semi-continuous operation yielded smaller and less aggregated populations than the batch operation. The releasebehaviour of acetazolamide from the prepared microparticles was studied and most products exhibited a slower release than the single drug.Moreover, the release could be controlled to some extent by varying the ratio of the two Eudragit used in the formulation and by selecting oneor the other anti-solvent technique. Simple diffusion models satisfactorily described the release profiles. Composites specifically produced bysemi-continuous technique have a drug release rate controlled by a diffusion mechanism, whereas for composites produced by the batch operation,the polymer swelling also contributes to the overall transport mechanism.
机译:评估了使用压缩反溶剂技术制备眼科药物输送系统的可能性。 RL 100为药物载体,乙酰唑胺为加工的模型药物。压缩的反溶剂实验是从聚合物+溶质溶解在丙酮中的液体溶液中以半连续或间歇方式进行的。两种技术都可以回收复合颗粒,但是半连续操作比批处理操作产生的聚集体越来越小。研究了制备的微粒中乙酰唑胺的释放行为,大多数产品的释放速度均比单一药物慢。此外,可以通过改变制剂中两种Eudragit的比例并选择一种或另一种来控制释放程度反溶剂技术。简单的扩散模型令人满意地描述了释放曲线。通过半连续技术专门生产的复合材料具有受扩散机制控制的药物释放速率,而对于通过分批操作生产的复合材料,聚合物溶胀也有助于整体转运机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号